FDA Updates Lumateperone Label With Relapse-Prevention Data
-
By
-
Kathryn Wighton
-
April 29, 2026
-
2 min
By
Kathryn Wighton
April 29, 2026
Behaviorally informed peer comparison feedback was associated with a gradual decline in glucocorticoid prescribing
May 11, 2026
Genetically predicted urinary metabolite levels were associated with schizophrenia, bipolar disorder, attention-deficit/hyperactivity disorder, and anorexia nervosa in a Mendelian randomization analysis.
May 15, 2026